Nectar Lifesciences Limited (NSE:NECLIFE)
India flag India · Delayed Price · Currency is INR
11.33
+0.04 (0.35%)
Mar 10, 2026, 1:20 PM IST

Nectar Lifesciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
2,1935,1476,7613,5775,3934,171
Upgrade
Market Cap Growth
-67.50%-23.88%89.03%-33.68%29.30%89.80%
Upgrade
Enterprise Value
6,71711,25113,37111,33114,30011,065
Upgrade
Last Close Price
11.2922.9530.1515.9524.0518.60
Upgrade
PE Ratio
--135.37-21.53-
Upgrade
PS Ratio
0.130.310.400.240.320.27
Upgrade
PB Ratio
0.310.540.630.340.500.39
Upgrade
P/TBV Ratio
0.310.570.670.350.520.41
Upgrade
P/FCF Ratio
-4.103.463.457.70-
Upgrade
P/OCF Ratio
-3.043.012.685.6819.51
Upgrade
EV/Sales Ratio
0.400.670.790.740.860.72
Upgrade
EV/EBITDA Ratio
--8.7121.009.0210.04
Upgrade
EV/EBIT Ratio
--14.40-14.0822.14
Upgrade
EV/FCF Ratio
-8.956.8510.9420.42-
Upgrade
Debt / Equity Ratio
0.640.610.590.710.790.85
Upgrade
Debt / EBITDA Ratio
--4.1413.975.428.19
Upgrade
Debt / FCF Ratio
-4.633.267.2812.28-
Upgrade
Net Debt / Equity Ratio
0.630.590.570.690.770.83
Upgrade
Net Debt / EBITDA Ratio
-16.89-21.564.0113.645.317.96
Upgrade
Net Debt / FCF Ratio
-4.473.157.1012.02-88.97
Upgrade
Asset Turnover
-0.790.770.670.700.62
Upgrade
Inventory Turnover
-1.831.621.601.781.39
Upgrade
Quick Ratio
-0.400.450.410.530.38
Upgrade
Current Ratio
-1.211.321.381.351.04
Upgrade
Return on Equity (ROE)
--11.23%0.47%-2.25%2.33%-6.67%
Upgrade
Return on Assets (ROA)
--2.61%2.65%-0.14%2.66%1.24%
Upgrade
Return on Invested Capital (ROIC)
-7.73%-5.52%1.46%-0.28%3.86%2.61%
Upgrade
Return on Capital Employed (ROCE)
--8.60%7.60%-0.40%7.30%4.20%
Upgrade
Earnings Yield
-161.89%-22.09%0.74%-6.76%4.64%-17.56%
Upgrade
FCF Yield
-24.41%28.88%28.96%12.98%-2.36%
Upgrade
Total Shareholder Return
1.69%-----
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.